These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 30876516)
1. From the CDC: The Prevention for States program: Preventing opioid overdose through evidence-based intervention and innovation. Robinson A; Christensen A; Bacon S J Safety Res; 2019 Feb; 68():231-237. PubMed ID: 30876516 [TBL] [Abstract][Full Text] [Related]
2. State-led opioid overdose prevention efforts: Challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS). Underwood N; Rooks-Peck C; Ali N; Wisdom A; Costa O; Robinson A; Mells J; Bacon S Subst Abus; 2021; 42(2):227-235. PubMed ID: 33798024 [No Abstract] [Full Text] [Related]
3. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018. Lee B; Zhao W; Yang KC; Ahn YY; Perry BL JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816 [TBL] [Abstract][Full Text] [Related]
4. Strategies and policies to address the opioid epidemic: A case study of Ohio. Penm J; MacKinnon NJ; Boone JM; Ciaccia A; McNamee C; Winstanley EL J Am Pharm Assoc (2003); 2017; 57(2S):S148-S153. PubMed ID: 28189539 [TBL] [Abstract][Full Text] [Related]
5. Promoting opioid overdose prevention and recovery: An exploratory study of an innovative intervention model to address opioid abuse. Powell KG; Treitler P; Peterson NA; Borys S; Hallcom D Int J Drug Policy; 2019 Feb; 64():21-29. PubMed ID: 30551002 [TBL] [Abstract][Full Text] [Related]
6. The Rhode Island community responds to opioid overdose deaths. Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658 [TBL] [Abstract][Full Text] [Related]
7. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493 [TBL] [Abstract][Full Text] [Related]
8. A scoping review of post opioid-overdose interventions. Bagley SM; Schoenberger SF; Waye KM; Walley AY Prev Med; 2019 Nov; 128():105813. PubMed ID: 31437462 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada. Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975 [TBL] [Abstract][Full Text] [Related]
10. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Pardo B Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931 [TBL] [Abstract][Full Text] [Related]
11. Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States. Chen Q; Larochelle MR; Weaver DT; Lietz AP; Mueller PP; Mercaldo S; Wakeman SE; Freedberg KA; Raphel TJ; Knudsen AB; Pandharipande PV; Chhatwal J JAMA Netw Open; 2019 Feb; 2(2):e187621. PubMed ID: 30707224 [TBL] [Abstract][Full Text] [Related]
12. Lessons Learned from Implementation of a Post-opioid Overdose Outreach Program in a Rural Massachusetts Community. Senthilkumar R; Bailey A; Moner E; Parduhn T; Evans EA Community Ment Health J; 2024 Apr; 60(3):482-493. PubMed ID: 37902945 [TBL] [Abstract][Full Text] [Related]
13. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality. Phillips E; Gazmararian J J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315 [TBL] [Abstract][Full Text] [Related]
14. The US Opioid Crisis: Current Federal and State Legal Issues. Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113 [TBL] [Abstract][Full Text] [Related]
15. Barriers to implementation of opioid overdose prevention programs in Ohio. Winstanley EL; Clark A; Feinberg J; Wilder CM Subst Abus; 2016; 37(1):42-6. PubMed ID: 26682929 [TBL] [Abstract][Full Text] [Related]
16. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning. Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159 [TBL] [Abstract][Full Text] [Related]
17. State Injury Programs' Response to the Opioid Epidemic: The Role of CDC's Core Violence and Injury Prevention Program. Deokar AJ; Dellapenna A; DeFiore-Hyrmer J; Laidler M; Millet L; Morman S; Myers L J Public Health Manag Pract; 2018; 24 Suppl 1 Suppl, Injury and Violence Prevention(Suppl 1 INJURY AND VIOLENCE PREVENTION):S23-S31. PubMed ID: 29189501 [TBL] [Abstract][Full Text] [Related]
18. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA; J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502 [TBL] [Abstract][Full Text] [Related]
19. Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia. Skoy E; Linger R; Eukel H; Murphy S; Frenzel O; Steig J; Strand M; Werremeyer A J Am Pharm Assoc (2003); 2024; 64(5):102152. PubMed ID: 38964591 [TBL] [Abstract][Full Text] [Related]